Cristina Mullenix

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “The role of immunotherapy for management of advanced thymic epithelial tumors: a narrative review”.

The role of immunotherapy for management of advanced thymic epithelial tumors: a narrative review

Mediastinum(2021)10.21037/med-20-62

N/A

0DataRank · unranked

7 citations

Cristina Mullenix, Meenakshi Shelat, Chen Zhao, Arun Rajan

Tolerability of Coronavirus Disease 2019 Vaccines, BNT162b2 and mRNA-1273, in Patients With Thymic Epithelial Tumors

JTO Clinical and Research Reports(2021)10.1016/j.jtocrr.2021.100229

N/A

0DataRank · unranked

8 citations

Shannon Swift, Cristina Mullenix, Yvonne Mallory, Chen Zhao, Éva Szabó +6 more

Reply to K. Takada et al.

JTO Clinical and Research Reports(2021)10.1016/j.jtocrr.2021.100250

N/A

0DataRank · unranked

0 citations

Cristina Mullenix, Éva Szabó, Seth M. Steinberg, Arun Rajan, Madison Ballman

Joint-Predominant Rheumatic Complications of Immune Checkpoint Inhibitor Therapy in Patients with Thymic Epithelial Tumors

The Oncologist(2022)10.1093/oncolo/oyac026

N/A

0DataRank · unranked

4 citations

Madison Ballman, Haobin Chen, Shannon Swift, Meredith J. McAdams, Yo-Ting Tsai +8 more

Durvalumab (D) in combination with olaparib (O) for advanced, previously treated non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e21153

N/A

0DataRank · unranked

3 citations

Rasa Vilimas, Cristina Mullenix, Chen Zhao, Éva Szabó, Meenakshi Shelat +6 more